What is Gyre Therapeutics, Inc.'s debt-to-assets?

Gyre Therapeutics, Inc. (GYRE) reported debt-to-assets of 0× in Q1 2026.

How has Gyre Therapeutics, Inc.'s debt-to-assets changed year-over-year?

Gyre Therapeutics, Inc.'s debt-to-assets decreased by 58.2% year-over-year, from 0× to 0×.

What is the long-term trend for Gyre Therapeutics, Inc.'s debt-to-assets?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s debt-to-assets has grown at a -19.9% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Gyre Therapeutics, Inc. GYRE Debt-to-assets

Debt-to-assets at other companies

Eli LillyLLY

0.4×-0.1×

Madrigal Pharmaceuticals, Inc.MDGL

0.3×+0.2×

Viking TherapeuticsVKTX

0×0.0×

Theravance BiopharmaTBPH

0.1×-0.1×

Rigel PharmaceuticalsRIGL

0.1×+0.1×

Zevra Therapeutics, Inc.ZVRA

0×-0.4×

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s debt-to-assets?: Gyre Therapeutics, Inc. (GYRE) reported debt-to-assets of 0× in Q1 2026.
How has Gyre Therapeutics, Inc.'s debt-to-assets changed year-over-year?: Gyre Therapeutics, Inc.'s debt-to-assets decreased by 58.2% year-over-year, from 0× to 0×.
What is the long-term trend for Gyre Therapeutics, Inc.'s debt-to-assets?: Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s debt-to-assets has grown at a -19.9% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.